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PURPOSE. To identify in human retinoblastoma and normal ret-
inal tissue the type of cadherin, its relationship with cytoplas-
mic catenins, and its participation in invasion.
METHODS. The cadherin/catenin complex was characterized in
surgical retinoblastoma specimens from five patients and hu-
man retinas from four donor eyes by immunocytochemistry,
flow cytometry, and coimmunoprecipitation with antibodies
against N-cadherin, -catenin, and -catenin, followed by West-
ern blot analysis or autoradiography. Y79 and WERI-Rb-1 reti-
noblastoma cell lines serve the evaluation of the cadherin/
catenin complex in aggregation and collagen type I invasion in
vitro. The association of the cadherin/catenin complex with
the cytoskeleton was examined by an antibody-capping assay.
RESULTS. In retinoblastoma and normal retina N-cadherin asso-
ciated with -catenin and -catenin but not E- or P-cadherin.
The N-cadherin/catenin complex formed a regular, linear, and
continuous honeycomb pattern in normal retina that was ir-
regular, clustered, and interrupted in retinoblastoma. The N-
cadherin/catenin complex was found also in the retinoblas-
toma cell lines WERI-Rb and Y79, in which it also showed an
irregular pattern. Both cell lines were invasive in collagen type
I, and invasion was inhibited by the GC-4 antibody, which
functionally neutralizes N-cadherin. Less GC-4 antibody was
needed to inhibit invasion of Y79 cells, which expressed N-
cadherin at a lower level, than to inhibit invasion of WERI-Rb-1
cells. In both cell lines, antibody capping of the N-cadherin/
catenin complex indicated that its linkage with the cytoskele-
ton were weak or absent.
CONCLUSIONS. Retinoblastoma cells, in contrast with normal
retina, express an N-cadherin/catenin complex that is irregu-
larly distributed and weakly linked to the cytoskeleton. In
retinoblastoma, this complex acts as an invasion promoter.
(Invest Ophthalmol Vis Sci. 2002;43:595–602)
Retinoblastoma originates from the inner nuclear layer ofthe retina. It is the most common intraocular tumor in
children, occurring with a frequency of 1 in 20,000 births.1,2
The development of retinoblastoma is initiated by deletion or
mutational inactivation of the RB tumor-suppressor gene on
chromosome 13q14, encoding a protein that interacts with E2F
transcription factors and regulates transcription of genes re-
quired for progression through the cell cycle.3 RB-deficient
neuroblasts lose control of proliferation, but still differentiate
and form a retinoma. Additional mutations—for example, in
Notch family genes—cause loss of differentiation, resulting in
retinoblastoma.2 The degree of invasion of retinoblastomas
into ocular coats and optic nerve is the main prognostic fac-
tor.4 Transgenic mice with one RB allele inactivated do not
form retinoblastomas, whereas the double-knockout RB/
mice are not viable.5,6 Transgenic mice, carrying the simian
virus (SV)40-T oncogene under the control of promoters for
eye-specific genes encoding interphotoreceptor retinoid-bind-
ing protein or opsin, show development of tumors resembling
human retinoblastomas.7 Similar lesions were obtained after
injection of human retinoblastoma cell lines Y79 and WERI-
Rb-1 into the subretinal space of adult Fischer 344 rats8 or into
the anterior chamber of nude mice.9 Injection of Y79 into the
vitreum of mice resulted in direct invasive spread to the optic
nerve, the brain, and contralateral optic nerve, whereas WERI-
Rb-1 cells invaded the anterior structures of the eye.4
Cadherins compose a superfamily of transmembrane mole-
cules that require calcium for their structure and function.
Members of the classic type I cadherin subfamily have a con-
served histidine-alanine-valine (HAV) cell adhesion recognition
sequence in their first extracellular domain10; Examples are the
N(euronal)- and E(pithelial)-cadherins.11 The catenins link the
cytoplasmic domain of classic cadherins to the cytoskeleton.
E-cadherin is an invasion suppressor, as demonstrated in ex-
perimental and human cancer.12–14 N-cadherin was originally
found in neuronal tissues,15 and later also in lens, skeletal, and
heart muscle cells16; osteoblasts17; and fibroblasts,18 where it
serves as an essential cell–cell adhesion molecule. Transient
N-cadherin expression is associated with rearrangement and
invasion of cells during morphogenesis.19 In prostate,20
breast,21 and head and neck squamous cell carcinomas,22 and
in melanomas,23 N-cadherin expression and increased invasive-
ness are associated with loss of a functional E-cadherin/catenin
complex. The latter has been explained through increased
motility of cancer cells when attached to N-cadherin–positive
stromal cells.22,24 The role of N-cadherin in cells migrating
from N-cadherin–positive normal tissues is less well under-
stood. When migrating, neural crest cells accumulate the bulk
of N-cadherin molecules in the detergent-soluble fraction, and
when restoring intercellular contacts, N-cadherin molecules
are recruited to the adherens junctions.25,26 The developing
retinas in chick and mice served as models for neurite out-
growth. In the models just described, direct heterophilic inter-
action between an HAV-binding motif on the fourth extracel-
lular domain of N-cadherin and an HAV motif on fibroblast
growth factor receptor (FGFR)-127 and also interaction be-
tween N-cadherin and 1 integrin complexes through phos-
phorylation cascades28,29 mediate neurite outgrowth.
So far, N-cadherin has not been investigated in normal
human retina or in retinoblastoma. In Y79 and WERI-Rb-1
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retinoblastoma cell lines a positive correlation was found be-
tween calcium-dependent aggregation and the amount of N-
cadherin expressed.30 In developing mouse and avian retinas,
N-cadherin is initially expressed in all undifferentiated retinal
cells. Later, steady loss of expression results in exclusive local-
ization of N-cadherin at the outer limiting membrane in the
chick19,31 or at the inner nuclear layer in the mouse.32 It was
our goal to study N-cadherin in human retinoblastoma by
immunohistochemistry and immunoprecipitation. The retino-
blastoma cell lines Y79 and WERI-Rb-1 were used to analyze
the putative invasion–stimulatory function of the N-cadherin/
catenin complex.
MATERIALS AND METHODS
Tissues and Cell Lines
Five samples of retinoblastoma (volume between 10 and 40 mm3) were
obtained from the operating theater and immediately snap frozen in
liquid nitrogen, with or without isopentane. Normal retina was dis-
sected from four donor eyes, obtained within 24 hours of death, that
were to be used for corneal transplantation. Choroid and retinal pig-
ment epithelium were dissected and snap frozen together with the
retina for correct orientation and sectioning. The human retinoblas-
toma cell lines Y7933 and WERI-Rb-11 (American Type Culture Collec-
tion, Manassas, VA) were cultured in RPMI 1640 (Gibco, Merelbeke,
Belgium), supplemented with 15% fetal calf serum (FCS; Gibco), 2 mM
L-glutamine, 100 IU/mL penicillin, 100 g/mL streptomycin, and 2.5
g/mL amphotericin B. Human neuroblastoma cells SK-N-SH34 served
as a positive control in molecular, immunocytochemical, and func-
tional analyses of human N-cadherin–expressing cells.35 ARM cells,
which are mouse sarcoma cells transfected with chicken cDNA encod-
ing N-cadherin, were used as a positive control for invasive cells
expressing N-cadherin.36 The dog kidney epithelial cells MDCK/AZ37
and the spontaneously immortalized rat enteric myofibroblasts DHD-
Fib38 were used as noninvasive and invasive controls, respectively, in
the collagen type I invasion assay.
Antibodies and Reagents
Rabbit polyclonal antibodies (Sigma, Bornem, Belgium), raised against
a peptide homologous to the C-terminal part (amino acids 890-901) of
human -catenin (the same for E and N) and against a peptide
corresponding to the C-terminal part (amino acids 768-781) of human
-catenin, were used for immunoprecipitation, immunostaining on
Western blot (diluted 1:1000), and immunocytochemistry (diluted
1:500). The mouse monoclonal antibody recognizing the extracellular
domain of both chicken and human N-cadherin (A-CAM, clone GC-4;
Sigma, St. Louis, MO) was used for immunocytochemistry (diluted
1:30). A purified mouse monoclonal IgG1 clone (11711.11; R&D Sys-
tems, Minneapolis, MN) was used as isotype control antibody in the
collagen type I invasion assay. GC-4 without azide39 was used for the
capping assay (diluted 1:30) and the collagen type I invasion assay (at
different dilutions, as described in the Results section). The mouse
monoclonal antibody raised against the human N-cadherin cytoplasmic
domain (13A9), kindly provided by Margaret J. Wheelock (Department
of Biology, University of Toledo, Toledo, OH), was used for immuno-
precipitation and immunostaining on Western blot (diluted 1:500).
The rabbit polyclonal antibody CH-19 (diluted 1:1000; Sigma), raised
against the C-terminal part of chicken N-cadherin; the monoclonal
antibody HECD-1 (diluted 1:1000), recognizing the extracellular do-
main of E-cadherin (Takara, Kyoto, Japan); and the monoclonal anti-
body raised against a peptide homologous to the N-terminal part
(amino acids 72-259) of P-cadherin (diluted 1:1000; BD Bioscience, HQ
Pharmingen, Schwechat, Austria), were used for immunostaining on
Western blot.
Immunoprecipitation, Gel Electrophoresis,
Western Blot analysis
For immunoprecipitation, lysates were prepared from tumor fragments
and cell cultures in phosphate-buffered saline (PBS) containing 1%
Triton X-100, 1% NP-40, and the following protease inhibitors (all from
Sigma): 1.72 mM phenylmethylsulfonyl fluoride, 21 M leupeptin, and
10 g/mL aprotinin. Equal amounts of protein were incubated with
protein G Sepharose beads for 1 hour, the beads were discarded, and
the supernatant was incubated with primary antibody (1 g/precipi-
tation) for 3 hours at 4°C followed by protein G Sepharose beads for 1
hour. Precipitated proteins were dissolved in sample buffer,40 boiled in
the presence of 5% mercaptoethanol, separated by 7.5% SDS-PAGE,
and transferred onto membranes (Immobilon-P; Millipore Corp., Bed-
ford, MA). After quenching with 5% nonfat dry milk containing 0.5%
Tween-20, the membranes were incubated with primary antibody,
followed by three washes for 5 minutes each and incubation with
either alkaline phosphatase–conjugated secondary antibodies (Sigma)
using nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate
(NBT/BCIP) as a substrate or horseradish peroxidase–conjugated sec-
ondary antibodies with enhanced chemiluminescence (ECL) reagent
(Amersham Life Science, Buckinghamshire, UK) as a substrate. For
metabolic labeling, cells were incubated for 4 hours with 100 Ci/mL
Tran35S label, containing 70% L-methionine, [35S] (ICN Biomedicals,
Costa Mesa, CA) in methionine- and cysteine-free medium containing
2% FCS, followed by washing and extraction in PBS containing 1%
Triton X-100, 1% NP-40, 1.72 mM phenylmethylsulfonyl fluoride, 21
M leupeptin, 10 g/mL aprotinin, 0.9 mM CaCl2, and 0.334 mM
MgCl2. After lysates were diluted to contain equal amounts of trichlo-
roacetic acid–precipitable radioactivity, immunoprecipitation, gel elec-
trophoresis, and Western blot analyses were further used as as for
nonmetabolic labeled cells. Blots containing 35S methionine–labeled
proteins were exposed to autoradiographic film.
Immunocytochemistry and
Immunohistochemistry
Subconfluent cultures of SK-N-SH cells on glass coverslips were fixed in
methanol (20°C) for immunocytochemical staining. Aspecific bind-
ing of the primary antibody was blocked by incubation for 30 minutes
with 5% bovine serum albumin. Subsequently, SK-N-SH cells were
incubated with the primary antibody at room temperature for 90
minutes, followed by FITC-labeled anti-mouse (diluted 1:20) or biotin-
ylated anti-rabbit immunoglobulins (diluted 1:50; Amersham) for an-
other 90 minutes. Thereafter, cells were incubated for 15 minutes with
Texas red–conjugated streptavidin (diluted 1:50) and 4,6-diamino-2-
phenylindol (DAPI, 0.4 mg/mL; Sigma) to stain the nuclei. Coverslips
were mounted in aqueous medium (Glycergel; Dako, A/S, Glostrup,
Denmark), examined by fluorescence microscopy (Dialux 20; Leitz,
Wetzlar, Germany), and photographed with a camera system (Ortho-
mat E; Leitz). Y79 and WERI-Rb-1 cells were stained in suspension.
Therefore, 1.2 million cells/mL were washed with PBS, followed by
fixation with paraformaldehyde 3%. For staining of - and -catenin,
Y79 and WERI-Rb-1 cells were permeabilized with Triton X-100 (0.2%).
Cells were immunostained, as described for SK-N-SH cells. After immu-
nostaining, 20 L of Y79 and WERI-Rb-1 cell suspensions were either
dried on poly-L-lysine–coated coverslips, mounted in gelatin, and pho-
tographed with the camera system (Orthomat E; Leitz) or analyzed by
flow cytometry (FACSort; BD Biosciences; Mountain View, CA). Flow
cytometric results were analyzed with Kolmogorov-Smirnov statistics.
For capping experiments on N-cadherin at the cell surface, SK-N-
SH, WERI-Rb-1, and Y79 cells were treated in suspension. Therefore,
SK-N-SH cells were first detached in cadherin-saving conditions.41
Briefly, cells were detached by collagenase A (Roche Molecular Bio-
chemicals, Mannheim, Germany) followed by trypsin, both in presence
of Ca2 at 0.04 mM. Unfixed SK-N-SH, WERI-Rb-1, and Y79 cell sus-
pensions were then treated further at 4°C.42 Cells were washed with
PBS, treated for 1 hour with GC-4 antibody without azide, spun for 2
minutes at 350 g, and treated with FITC-labeled anti-mouse immuno-
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globulins for 30 minutes. Cells were further incubated at 37°C, and the
fluorescent signal was evaluated microscopically every 10 minutes.
For immunohistochemical staining, 5-m-thick sections from iso-
pentane-coated frozen retinoblastoma and nontumorous retina were
fixed in methanol and stained as described for immunocytochemical
staining of SK-N-SH cells seeded on coverslips. Immunostained sections
were mounted in aqueous medium (Glycergel; Dako).
Functional Assays
The collagen type I invasion assay was performed as described.43
Briefly, collagen G (type I solution; Seromed, Biochrom KG, Berlin,
Germany) was dissolved at 0.22% in bicarbonate buffer, containing
DMEM. Aliquots (1.2 mL) were poured into a six-well plate and incu-
bated overnight at 37°C for gelation. Cells were seeded on top of the
collagen gel, with or without GC-4 antibody, against N-cadherin. After
a 24-hour incubation at 37°C, the number of cells that invaded the gel
was counted under a phase-contrast microscope with a computer-
controlled step motor.44 The invasion index was expressed as the
number of cells inside the gel relative to the total number of cells.
Student’s t-test (95%) was used for statistical analysis. A fast aggregation
assay was performed as described previously.41 Single-cell suspensions
were prepared in accordance with a cadherin-saving procedure and
incubated in an isotonic buffer containing 1.25 mM Ca2 under shak-
ing (Gyrotory; New Brunswick Scientific, New Brunswick, NJ) at 80
rpm for 30 minutes, with or without GC-4 antibody against N-cadherin
(diluted 1:50). Particle diameters were measured in a particle size
counter (LS 200; Coulter, Lake Placid, NY) at the start (N0) and after 30
minutes of incubation (N30) and plotted against percentage volume
distribution.
RESULTS
N-Cadherin/Catenin Complex in Human
Retinoblastoma Compared with Normal Retina
Normal retina tissues (4 of 4 samples) expressed N-cadherin,
-catenin, and -catenin. The expression pattern of N-cadherin
was not limited to the outer limiting membrane, as in the
chick,19,31 or to the inner nuclear layer, as in the mouse,32 but
was found in the inner and outer nuclear layers, as well as the
outer limiting membrane. -Catenin and -catenin were found
in the same layers of the retina as N-cadherin, and all were
organized in a regular honeycomb pattern, as illustrated in
Figure 1. In retinoblastoma, the honeycomb pattern of N-
cadherin, -catenin, and -catenin was irregular, with clusters
of the three proteins throughout the tissue. In none of the
investigated retinoblastomas was -catenin seen in the nucleus.
E- or P-cadherin was not expressed in normal retina or in
retinoblastoma (data not shown). Immunostaining on Western
blot confirmed the qualitative immunohistochemical findings.
Moreover, N-cadherin, -catenin, and -catenin showed less
immunoreactivity per unit protein weight in retinoblastoma
than in normal retina. A pancadherin antibody, raised against
the C-terminal part of chicken N-cadherin and recognizing
class I cadherins, showed the same reactivity on Western blot
as the 13A9 antibody that specifically recognized N-cadherin. It
was concluded that N-cadherin, -catenin, and -catenin form
a complex in both retinoblastoma and normal retina, in that
not only was N-cadherin precipitated with -catenin, but
-catenin was precipitated with N-cadherin, and -catenin was
associated with -catenin and N-cadherin immunoprecipitates.
Characterization of the Cadherin/Catenin
Complex in Y79 and WERI-Rb-1 Cells
To investigate the function of N-cadherin in cellular invasion,
the Y79 and WERI-Rb-1 cell lines were used. N-cadherin,
-catenin, and -catenin were found in all lysates from SK-N-SH
and WERI-Rb-1 cells, which indicated that the three proteins
are organized in an N-cadherin/catenin complex (Fig. 2A). The
immunoreactivity of the N-cadherin/catenin complex in WERI-
Rb-1 cells was less intense than in SK-N-SH cells. Because
immunostaining of Western blot analysis of total cell lysates
from WERI-Rb-1 cells also showed lesser reactivity than total
cell lysates from SK-N-SH cells (data not shown), it was con-
cluded that the fainter reactivity for the N-cadherin/catenin
complex was due to a lesser amount of N-cadherin/catenin
complexes expressed in WERI-Rb-1 cells and not to a failure to
immunoprecipitate the N-cadherin/catenin complex in WERI-
Rb-1 cells. In Y79 cells, there was only a faint reactivity for -
and -catenin and no reactivity for N-cadherin. A more sensi-
tive method was therefore used for the detection of an N-
cadherin/catenin complex in Y79 cells. Autoradiography of a
7.5% SDS-polyacrylamide gel of N-cadherin, -catenin, and
-catenin immunoprecipitates from lysates of cells labeled with
35S methionine showed bands at 135 kDa (N-cadherin), 102
kDa (-catenin), and 94 kDa (-catenin) in the three immuno-
precipitates from Y79 and WERI-Rb-1 cells (Fig. 2B). Flow
cytometry of SK-N-SH, WERI-Rb-1, and Y79 cells confirmed
these findings (Fig. 2C). N-cadherin was expressed by the three
cell lines, with SK-N-SH showing the highest and Y79 the
lowest intensity. WERI-Rb-1 and Y79 cells showed an irregular
staining pattern with a disrupted honeycomb and clustered
N-cadherin, -catenin, and -catenin, as seen in retinoblastoma
tissue (Fig. 3).
The capping assay was performed to evaluate the strength
of the association of the N-cadherin/catenin complex with the
cytoskeleton.45 At 4°C, fluorescent immunosignals indicating
N-cadherin were equally distributed over the cell surface in the
three cell types (Fig. 4). After a shift of temperature from 4°C
to 37°C, the fluorescent signal gradually capped at one pole of
WERI-Rb-1 and Y79 cells within 30 minutes of incubation,
FIGURE 1. Normal retina and retinoblastoma express an N-cadherin–
catenin complex. (A) Immunofluorescence micrographs of retinoblas-
toma and neuroretina stained for -catenin. Frozen sections were
immunostained with an antibody against -catenin. Normal retina
showed a regular honeycomb pattern (arrowhead). In retinoblastoma
the honeycomb pattern was interrupted and showed clusters (arrow).
(B) Western blot analysis of -catenin () and N-cadherin (N) immu-
noprecipitates of lysates from the same neuroretina and retinoblastoma
as shown in (A). Precipitated proteins were separated by 7.5% SDS-
PAGE, transferred onto membrane, and immunostained (IS) with anti-
bodies recognizing N-cadherin (N; 13A9), E-cadherin (E; HECD-1),
P-cadherin (P), pancadherin (pan; CH-19), -catenin (), or -catenin
(). Even and uneven numbered lanes represent retinoblastoma and
normal retina, respectively. Scale bar, 20 m.
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whereas it remained equally distributed over the surface of
SK-N-SH cells. We concluded from this observation that in the
retinoblastoma cell lines, the N-cadherin/catenin complex was
not or was only weakly linked to the actin cytoskeleton.
Role of N-Cadherin in Aggregation and Invasion
of Y79 and WERI-Rb-1 Cells
SK-N-SH, WERI-Rb-1, and Y79 cells aggregated after 30 min-
utes, with quantitative differences between cell types (Fig. 5).
Treatment with GC-4 antibody inhibited aggregation of SK-
N-SH and WERI-Rb-1, but not Y79 cells. WERI-Rb-1 and Y79
retinoblastoma cells do not attach to solid tissue culture sub-
strate, but grow as loose aggregates in suspension. By contrast,
FIGURE 2. WERI-Rb-1 and Y79 retinoblastoma cells expressed an N-
cadherin/catenin complex. (A) Western blot analysis of N-cadherin (N;
CH-19), -catenin (), and -catenin () immunoprecipitates (IP) from
retinoblastoma cell lysates. SK-N-SH cells were used as a positive
control for N-cadherin, -catenin, and -catenin expression. Precipi-
tated proteins were separated by 7.5% SDS-PAGE, transferred onto
membrane, and immunostained (IS) with antibodies recognizing N-
cadherin (13A9), -catenin, or -catenin. (B) Autoradiographs of 7.5%
SDS-polyacrylamide gels of lysates from retinoblastoma cells labeled
with Tran35S methionine, containing 70% L-methionine, [35S], and
immunoprecipitated (IP) with an antibody against N-cadherin (N;
13A9), -catenin (), or -catenin (). Arrows: positions of N-cadherin,
- and -catenin in accordance with molecular weight. (C) Flow
cytometry of SK-N-SH (S), WERI-Rb-1 (W), and Y79 (Y) cells, labeled
with GC-4 antibody, which recognizes N-cadherin (dilution 1:30),
followed by fluorescein-linked secondary antibody. Cells labeled with
fluorescein-linked secondary antibody alone were used as blank (B)
control. Abscissa: relative fluorescence intensity; ordinate: number of
cells.
FIGURE 3. Neuroblastoma and retinoblastoma cells showed a different
staining pattern for N-cadherin, -catenin, and -catenin. Immunoflu-
orescence micrographs of SK-N-SH cells (A, B, C) showing a regular
honeycomb pattern, and WERI-Rb-1 (D, E, F), and Y79 (G, H, I) cells
showing an interrupted honeycomb pattern with clusters. Scale bar, 25
m.
FIGURE 4. GC-4 antibody–mediated capping by N-cadherin in WERI-
Rb-1 and Y79 cells. Immunofluorescence micrographs of living SK-
N-SH (A, D), WERI-Rb-1 (B, E), and Y79 (C, F) cells. Cells in suspension
were labeled at 4°C with GC-4 antibody recognizing N-cadherin, fol-
lowed by rabbit anti-mouse FITC. Photographs were taken immediately
after cells were brought to 37°C (t  0) or 30 minutes later (t  30).
Arrows: capping. Scale bar, 20 m.
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these cells attach to collagen type I, presumably through 1
integrins,46,47 and they invaded the collagen gel within 24
hours (Fig. 6). The GC-4 antibody, which functionally neutral-
izes N-cadherin,48 significantly reduced the invasion index of
ARM, SK-N-SH, Y79, and WERI-Rb-1 cells expressing chicken or
human N-cadherin (Fig. 6A). The IgG1 isotype control antibody
had no significant effect on invasion. The amount of GC-4
antibody needed to inhibit invasion was much lower for Y79
cells than for WERI-Rb-1 and SK-N-SH cells (Fig. 6B).
DISCUSSION
The N-cadherin/catenin complex, observed in normal retina,
was disturbed in retinoblastoma, as evidenced by the irregular
immunocytochemical staining pattern and the reduced levels
of its elements in Western blot analysis. Such disturbed pat-
terns have been described for the E-cadherin/catenin complex
in most epithelial cancers, in which the complex serves as an
invasion suppressor.49 For tumors originating from N-cad-
herin–positive cells, the role of the N-cadherin/catenin com-
plex in invasion is less well defined. In ovarian carcinomas,
N-cadherin expression was used to define the origin of the
tumor.50 In astrocytomas and glioblastomas of the same his-
topathologic grade, no correlation has been found between
FIGURE 5. GC-4 antibody against N-cadherin inhibited aggregation of
SK-N-SH and WERI-Rb-1, but not Y79 cells. Volume percentage distri-
bution of the diameter of SK-N-SH (A), WERI-Rb-1 (B), and Y79 (C)
aggregates. Cells were detached under cadherin-saving conditions,
suspended in aggregation buffer, and allowed to aggregate for 30
minutes in the presence (filled symbols) or absence (open symbols) of
GC-4 antibody. Cell aggregation was measured by particle size count-
ing either after 0 minutes (unsymboled traces) or 30 minutes of
aggregation. Komogorov-Smirnov statistics were used to analyze the
differences between the cumulative particle size distribution curves.
*Statistical difference for P  0.001.
FIGURE 6. Collagen type I invasion was inhibited by the GC-4 anti-
body, which neutralizes N-cadherin. (A) Cells (1  105) were seeded
on a layer of collagen type I without (filled bars) or with GC-4 antibody
(dilution 1:30; dotted bars) or with IgG1 isotype control antibody
(open bars). Invasion indices were calculated as the number of cells
inside the gel relative to the total number of cells. Each bar represents
mean data from three experiments, and flags show SDs, except for
IgG1 antibody treatment, which represents one experiment. The inva-
sion index of IgG1-treated cells differed from that of GC-4-treated cells
but not from that of untreated cells (Student’s t-test, P  0.005). ARM
and SK-N-SH cells served as a positive control for cells that expressed
N-cadherin and invaded collagen type I. DHD-FIB and MDCK/AZ cells
served as the control for cells that were invasive and noninvasive,
respectively, of collagen type I. (B) Dose–response curve of inhibition
of invasion of SK-N-SH cells (), WERI-Rb-1 cells (Œ), and Y79 cells (F)
by GC-4 antibody. Abscissa: GC-4 antibody dilution; ordinate: invasion
index expressed as a percentage of untreated cells.
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invasion and amount of N-cadherin.51 In neuroblastomas such
a correlation has not been examined.35 Transfection with
cDNA-encoding N-cadherin rendered breast carcinoma cells
invasive in synthetic basement membrane (Matrigel; BD Bio-
sciences).52 Our present observations show that N-cadherin
promoted invasion of retinoblastoma cells, at least in vitro. Y79
and WERI-Rb-1 retinoblastoma cell lines expressed N-cadherin
and invaded collagen type I. Invasion was inhibited by the GC-4
antibody that binds to the extracellular part of N-cadherin and
functionally neutralizes the molecule.39 Although Y79 cells
expressed less N-cadherin than WERI-Rb-1 cells, their invasion
index was the same. The amount of antibody needed to inhibit
invasion, however, was proportional to the amount of N-cad-
herin expressed by the cells. Also in astrocytoma and glioblas-
toma cell lines, low expression of N-cadherin was compatible
with high cellular motility.51
N-cadherin may support stable cell–cell adhesion and also
stimulate migratory processes such as neurite outgrowth in
vitro53 and invasion in retinoblastoma. These apparently anti-
thetic functions are explained by the fact that N-cadherin may
be either mobile in the plane of the plasma membrane or may
participate in the formation of stable adherens junctions that
are linked to the cytoskeleton.54 Indeed, in migrating neural
crest cells, the bulk of N-cadherin molecules was found in the
2.5% Triton-soluble fraction. After treatment with tyrosine ki-
nase or phosphatase inhibitors, stable N-cadherin–mediated
intercellular contacts were restored.25,55 Our experiments in-
dicate that, in retinoblastoma, the majority of N-cadherin mol-
ecules are not firmly linked to the cytoskeleton. First, the GC-4
antibody caused capping of N-cadherin at one pole of Y79 and
WERI-Rb-1 cells, as observed also for E-cadherin in human
colon cancer cells HCT-8/E11R1 without -catenin, an element
that is necessary to link E-cadherin to the cytoskeleton (Marc
Bracke, personal communication, May 2001).56 Two, the dis-
turbed immunohistochemical pattern of N-cadherin found by
us in retinoblastoma resembled that in high-grade, highly inva-
sive prostate cancer.20
Taken together, these observations suggest that in the nor-
mal retina, N-cadherin is coupled to the cytoskeleton and
serves cell–cell adhesion as an element of adherens junctions,
whereas in retinoblastoma N-cadherin is released from the
cytoskeleton and participates in cellular invasion. Western blot
analysis of detergent extracts with 0.1% and 1% Triton X-100
from colon cancer cells HCT-8/E11 and their -catenin–nega-
tive variant HCT-8E11R1, human retinal pigment epithelial
(RPE) cells at passage 5, retinoblastoma cells WERI-Rb-1, or
Y79 did not contribute to our understanding. We found no or
very minor differences in detergent solubility of N-cadherin,
E-cadherin, -catenin, -catenin, or actin (Van Aken et al.,
unpublished results, 2001).
Several mechanisms may underlie stimulation of invasion by
N-cadherin. In chick embryos, N-cadherin mediates outgrowth
of retinal ganglion cells through homophilic, homotypic inter-
action with other neurons or homophilic, heterotypic interac-
tions with other N-cadherin–expressing cells, such as oligo-
dendrocytes.57 Axon and dendrite outgrowth are impaired by
transfection of the eye primordia with a mutant with a large
deletion in the extracellular domain, but not with a mutant
consisting of the cytoplasmic domain and competing for cate-
nin binding, suggesting that the extracellular part, but not the
catenin-binding part, of N-cadherin is essential for retinal out-
growth. The migration of single cells through synthetic base-
ment membrane (Matrigel; BD Biosciences)–coated filters de-
pended on the heterophilic interaction between N-cadherin
and FGFR152 or the indirect interaction between N-cadherin
and 1 integrin through phosphorylation cascades. N-cad-
herin–FGFR1 interaction has been extensively analyzed in neu-
rite outgrowth of retinal ganglion cells and in pheochromocy-
toma cells.27,53,58,59 Cis interaction between the HAV-binding
motif of the fourth extracellular domain of N-cadherin and the
HAV motif between the first and second immunoglobulin-like
domain of FGFR1 results in increased mitogen-activated pro-
tein kinase (MAPK) activation and matrix metalloproteinase
(MMP)-9 transcription.60 The link with FGFR1 may be realized
through transmembrane native N-cadherin or by N-cadherin
fragments shed into the collagen.61 N-cadherin fragments (90
kDa) are products of the naturally occurring proteolytic turn-
over that stimulate neurite outgrowth as potently as native
N-cadherin molecules.62 N-cadherin–1 integrin interaction, as
retinoblastoma cells bound to collagen type I through 1
integrins,46 has been described in migrating retinal neurons
and myoblasts.28,55,63,64 It has been hypothesized that, in the
developing chick retina, activation of a GalNAcPTase by its
ligand neurocan results in translocation of Fer kinase from the
N-cadherin/catenin complex to the 1 integrin complex. As in
the N-cadherin/catenin complex, loss of phosphorylated active
protein tyrosine phosphatase 1B would result in hyperphos-
phorylated -catenin and the uncoupling of N-cadherin from
the actin cytoskeleton. The 1 integrin complex would be
inactivated by phosphorylation of p130cas-binding partners. As
a result, the integrin complex is rendered nonfunctional and
migration of neurites is inhibited.
In another in vitro assay using embryonic chick heart as a
substrate, WERI-Rb-1 and Y79 cells failed to invade (Van Aken
et al., unpublished results, 2001), in line with the findings of
others.65 This observation illustrates again the dependence of
invasion on the elements of the host that may either stimulate
or inhibit invasion.66,67 Moreover, it cautions against extrapo-
lation of our experimental observations to the complex situa-
tion in retinoblastoma in vivo.
The present aggregation experiments with WERI-Rb-1 and
Y79 cells confirmed others’ results.30 In the latter and in our
experiments, N-cadherin participated in the aggregation of
WERI-Rb-1, but not Y79 cells, as evidenced by trituration in
Ca2-free compared with Ca2-containing medium30 and by
aggregation in the presence or absence of neutralizing GC-4
antibody (our present experiments). Absence of inhibition by
antibody in Y79 and partial inhibition in WERI-Rb-1 cells is
evidence for the participation of other adhesion molecules,
such as nerve cell adhesion molecule (NCAM) and L1, that
belong to the Ca2-independent immunoglobulin superfamily.
In conclusion, normal retina and retinoblastoma both express
an N-cadherin/catenin complex. In normal retina, N-cadherin is
localized at the adherens junctions serving cell–cell adhesion,
whereas in retinoblastoma, N-cadherin is released from the
cytoskeleton and participates in cellular invasion.
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